Insights On Trial Design

  1. Overcoming Complex Patient Recruitment Challenges With Data 4/15/2025

    Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.

  2. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  3. CRF Validation Best Practices: Building Reliable Clinical Trial Databases 6/29/2026

    CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

  4. Unique IRT Implementation Considerations For Personalized Medicine Trials 8/22/2025

    The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.

  5. From Protocol Design To Actual Patients In Studies 4/22/2026

    Explore how clinical trial success increasingly depends on aligning recruitment strategies with protocol complexity through data-driven insights and tailored engagement approaches.

  6. IRT: A New Approach To Meeting The Needs Of Early Phase Trials 8/14/2025

    As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

  7. How Protocol Design Decisions Shape Recruitment, Data Quality & Study Startup 6/29/2026

    Protocol design directly affects recruitment, data quality, and startup speed. Clear workflows, streamlined criteria, and early alignment reduce delays, amendments, and improve reliable study execution.

  8. Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study 1/6/2025

    Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

  9. Meeting Regulatory And Patient Needs By Improving Clinical Trial Access 3/26/2026

    Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

  10. Reducing The Burden Of Patient Retention And Improving Continuity 1/6/2026

    Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.